Zealand Pharma — December 2025
-
-
tak @bullish
-
Zealand Pharma: Kan de overbevise ved at gentage deres vægttabsbudskab? https://proinvestor.com/boards/130196
-
CMD på torsdag
-
Spørgsmål til Q&A d. 18. december er meget velkommen.
-
JP Morgan sänker riktkursen för Zealand Pharma till 1 000 danska kronor (1 050), upprepar övervikt - BN
-
Pfizer øger satsning på vægtbehandling med licensaftale til 2,1 mia. dollar https://proinvestor.com/investornyt/1391839/pfizer-oger-satsning-pa-vaegtbehandling-med-licensaftale-til-21-mia-dollar
-
FED sænker sandsynligvis renten - hvad nu? Vi ser på Genmabs data, Bavarians vigtige investormøde og Zealands store pengetank. Kan Wegovy-pillen og aktietilbagekøb vende stemningen i Novo Nordisk? Få svar på det og meget mere i afsnit 301 af Investeringspodcasten. https://proinvestor.com/boards/130232
-
Zealand Pharma outlines Metabolic Frontier 2030 strategy to become a generational biotech leader in obesity and metabolic health Tilmelding til kapitalmarkedsdag: https://zealand-pharma-capital-markets-day-dec-25.open-exchange.net/registration
-
Zealand Pharma and OTR Therapeutics enter multi-program strategic collaboration and license agreement to develop novel therapeutics for metabolic diseases
-
Collaboration will combine Zealand Pharma’s expertise in obesity and metabolic health with OTR Therapeutics’ proprietary oral small-molecule platform and strong drug discovery capabilities, to discover and develop novel therapeutics for multiple targets in metabolic diseases
-
OTR Therapeutics will receive an initial upfront payment of USD 20 million, which may increase to USD 30 million under certain pre-agreed conditions, and is eligible for potential preclinical, development, regulatory, and commercial milestone payments, for a potential total consideration of up to USD ~2.5 billion, with the majority representing commercial milestones, plus tiered royalties
-
Zealand Pharma indgår nyt samarbejde med OTR Theraputics https://proinvestor.com/investornyt/1392308/zealand-pharma-indgar-nyt-samarbejde-med-otr-theraputics
-
Zealand Pharma klar med ny strategi: Vil være leder i fedme og stofskiftesygdomme
https://proinvestor.com/investornyt/1392315/zealand-pharma-klar-med-ny-strategi-vil-vaere-leder-i-fedme-og-stofskiftesygdomme -
Ugevideo: Zealand Pharma, Genmab, Bavarian, Nanexa & Novo https://proinvestor.com/boards/130256
-
Godmorgen, der skrues op for investeringerne i forskning: https://medwatch.dk/brancher/Medicinal___Biotek/article18835248.ece
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind